Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:172 (26 January), doi:10.1136/bmj.39465.485972.BE
| The first 150 words of the full text of this article appear below. |
Blaggs states that home haemodialysis (HD) is cost effective.1 In the United States, where there is less likelihood of receiving a cadaveric transplant than in the United Kingdom (45% v 30%), the economics are different. In the United Kingdom the break even point on the set up and running costs of home HD v in-centre HD is about two years. Analysis of data from the UK Renal Registry shows that within 20 months of starting, half of the patients receiving home HD would have received a kidney transplant. This makes the cost neutral point towards 3-4 years.
It will always be difficult to show that home HD improves survival as patients on the home HD programme in any renal unit are always highly selected. They are unlikely to have any comorbid conditions and have good fistulas (not central lines). It is difficult even with age matching to allow for all
David Ansell, director, UK Renal Registry
1 Southmead Hospital, Bristol BS10 5 NB
david.ansell@nbt.nhs.uk